Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Stacy Alan Brethauer, MD, is a Staff Physician in the Section of Laparoscopic and Bariatric Surgery at Cleveland Clinic. He attended the University of Colorado, Boulder, Colo., from 1985 to 1989, where he studied journalism and mass communication. He attended medical school at Uniformed Services University of Health Sciences-F. Edward Hebert School of Medicine, in Bethesda, MD and received his MD degree in 1993. After serving three years as a carrier air wing flight surgeon, he completed general surgery residency at the Naval Medical Center in San Diego, CA in 2001. Following residency, he was assigned as a staff general surgeon in Okinawa, Japan and at the Naval Medical Center, San Diego. He completed a research fellowship and a clinical fellowship at the Cleveland Clinic and joined the staff in 2007. His clinical interests include bariatric surgery, laparoscopic surgery, gastrointestinal surgery, hernia repair and endoscopy.
He is the Director of Bariatric Surgery at Fairview Hospital and Associate Program Director for the Advanced Laparoscopic and Bariatric Surgery Fellowship program.
He serves on the executive council for the American Society for Metabolic and Bariatric Surgery (ASMBS) and the board of governors for the ASMBS Foundation. He is involved in a variety of national committees and task forces focusing on quality and accreditation in bariatric surgery.
Advanced laparoscopy & endoscopy, bariatric operations, Bariatric Surgery, Endoscopy, Endoscopy in the Obese Patient, Gastric surgery with focus on reflux disease, Gastric cancer, gastrointestinal surgery, General Surgery, hernia repair, Hiatal Hernia, Laparoscopic Surgery, Obesity, surgery and endoluminal surgery, weight loss surgery
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 1/4/2014, Dr. Brethauer has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.